hotspot -WSS

hotspot

author：entertainment 2025-09-30 20:06:13 - browse：62

Illumina said Monday afternoon that its board of directors had approved a spin-off of its cancer test subsidiary Grail, signaling that a nearly four-year-long, $8 billion saga will finally draw to a close this month.

Shares in the newly independent Grail are expected to be distributed on June 24, Illumina said in a statement. Illumina will retain a 14.5% stake in the company, which will trade under the ticker $GRAL.

It’s the second time Illumina has spun off Grail, which initially began as a unit within the DNA sequencing giant in 2015. Illumina turned it into an independent company the following year but then agreed to reacquire it for $8 billion in September 2020.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： CDC Director Mandy Cohen on transparency, trust, and health

hotspot

WSS

What to watch for from Zogenix and Amicus clinical trials

STAT Report: Patient voices and perspectives

Biden administration begins canceling student loan debt for 804,000 borrowers

Be careful with at

Senate panel puts off hardest PBM reforms for another day

Be careful with at

leisure time

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

explore

Medical leaders decry Supreme Court decision on affirmative action

Maui wildfire now ranks as the fifth

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Former reverend arrested for allegedly killing 8

Affirmative action in medical school literally saved lives

Maui wildfire now ranks as the fifth

Tori Bowie and the unacceptable rates of Black maternal death

Maui wildfire now ranks as the fifth

At least 13 dead in Texas as scorching temps continue

The battle over 'scope creep' and who gets to be called 'doctor'

focus

Why patients can’t get everything they want on drug pricing

Judge sides with young activists in first

Biden warns of ‘dark winter’ during final presidental debate

Illumina slashes 2023 revenue projections yet again

New Alzheimer's drugs heat up race for early detection blood tests

Hospitals are dialing back on venture capital investing

knowledge

hotspot

hotspot

hotspot